This past week the Human Unitec International Inc (OTC:HMNU) stock had been in focus among investors after it made a key new announcement with regards to one of its products. This week may be a good time for investors to consider taking a look at the announcement that was made by the company back on October 5.

Market Reaction

On Monday, HMNU stock ended flat at $0.0049 with 1.13 million shares, compared to its average volume of 4.52 million shares. The stock moved within a range of $0.0048 – $0.0051 after opening trade at $0.0051.

The company announced at the time that it had inked a strategic letter of intent with regard to an exclusive strategic agreement for the HMNU Medical Division. It was a major new development for Human Unitec International and one that must have been brought to the attention of both analysts as well as investors.

The binding letter of intent is for exclusive use at airport solid waste sterilizers, hospitals, and ports. Moreover, it was also announced that a joint venture had been created with Neutel SRL of Reggio Emilia in Italy.

The joint venture in question is going to be known as HMNU NEUTEL GROUP and it will be involved in the development as well as the marketing of mobile technologies. The technologies are going to be usually organized in the form of containers of standard sizes.

The technologies that are going to be implemented by the joint venture are going to consist of a wide range of capabilities. Some of the capabilities include sterilization of infectious solid wastes at hospitals, potable water, sterilization of naval and port waste, and contrast of localized epidemics among others.

Traders Review

HMNU stock is trading below the 20-Day and 50-Day Moving averages of $0.0053 and $0.0053 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.0062.

By Ruchika Gupta

I am Ruchika Gupta, a post-graduate woman. Having completed my Masters - in English. I like to write and thus have worked as a content writer for over nine years. I have gained much insight into the financial sector, having written plenty about it. Currently, I have been following up and writing on the biotech industry, which has given me handsome knowledge of the same.

Leave a Reply

Your email address will not be published.